ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
0.920
+0.017 (1.88%)
Dec 20, 2024, 4:00 PM EST - Market closed
ProMIS Neurosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | - | 0 | 0 | |
| Revenue Growth (YoY) | - | - | - | - | 30.20% | 153.05% | |
| Cost of Revenue | 8.54 | 7.88 | 16.09 | 4.63 | 3.18 | 4.74 | |
| Gross Profit | -8.54 | -7.88 | -16.09 | -4.63 | -3.18 | -4.73 | |
| Selling, General & Admin | 6.16 | 5.58 | 5.99 | 3.66 | 2.48 | 2.66 | |
| Operating Expenses | 6.16 | 5.58 | 5.99 | 3.66 | 2.48 | 2.66 | |
| Operating Income | -14.7 | -13.46 | -22.08 | -8.29 | -5.66 | -7.4 | |
| Interest Expense | -0.15 | -0.2 | -0.28 | -0.42 | - | - | |
| Interest & Investment Income | - | - | - | - | 0 | - | |
| Other Non Operating Income (Expenses) | 14.29 | 1.25 | 4.29 | -1.08 | - | - | |
| EBT Excluding Unusual Items | -0.56 | -12.41 | -18.07 | -9.79 | -5.66 | -7.4 | |
| Other Unusual Items | - | -0.8 | 0.01 | - | - | - | |
| Pretax Income | -0.56 | -13.21 | -18.06 | -9.79 | -5.66 | -7.4 | |
| Net Income | -0.56 | -13.21 | -18.06 | -9.79 | -5.66 | -7.4 | |
| Net Income to Common | -0.56 | -13.21 | -18.06 | -9.79 | -5.66 | -7.4 | |
| Shares Outstanding (Basic) | 22 | 12 | 8 | 6 | 5 | 4 | |
| Shares Outstanding (Diluted) | 22 | 12 | 8 | 6 | 5 | 4 | |
| Shares Change (YoY) | 132.70% | 63.85% | 29.68% | 21.55% | 9.93% | 8.61% | |
| EPS (Basic) | -0.03 | -1.07 | -2.41 | -1.69 | -1.19 | -1.71 | |
| EPS (Diluted) | -0.03 | -1.07 | -2.41 | -1.69 | -1.19 | -1.71 | |
| Free Cash Flow | -22.23 | -10.84 | -17.04 | -9.31 | -4.46 | -6.09 | |
| Free Cash Flow Per Share | -1.01 | -0.88 | -2.27 | -1.61 | -0.94 | -1.41 | |
| Operating Margin | - | - | - | - | -361828.37% | -615329.37% | |
| Profit Margin | - | - | - | - | -361814.19% | -615329.37% | |
| Free Cash Flow Margin | - | - | - | - | -285199.36% | -506627.70% | |
| EBITDA | -14.67 | -13.44 | -22.07 | -8.25 | -5.65 | -7.39 | |
| D&A For EBITDA | 0.03 | 0.02 | 0.01 | 0.05 | 0.02 | 0.01 | |
| EBIT | -14.7 | -13.46 | -22.08 | -8.29 | -5.66 | -7.4 | |
| Revenue as Reported | - | - | - | - | 0 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.